SEN COLLINS: STEM CELL RESEARCH HOLDS PROMISE

Washington, DC –Senator Susan Collins, a member of the Special Committee on Aging participated in a hearing today to explore the promise of embryonic stem cell research. The Committee focused on important progress being made in embryonic stem cell research and the need for additional stem cell lines. Senator Collins has long been a supporter of stem cell research, and believes that in order for embryonic stem cell research to proceed at a vigorous pace, the current restriction on federal funding for this research needs to be expanded.

"Embryonic stem cell research holds tremendous promise to treat and possibly even cure a vast array of devastating diseases and conditions, such as cancer, heart disease, diabetes, Parkinson's, Alzheimer's, multiple sclerosis, spinal cord injury, and many others. It is a promise that must be explored," Senator Collins said. "I have cosponsored a bill that will allow for advancement in this vital research while maintaining the highest ethical standards. I will continue to support expanded access to this vital research as the Senate considers this important issue."

Senator Collins is cosponsoring S. 471, the "Stem Cell Research Enhancement Act," which will make a vast number of unused cells available to researchers while respecting important ethical considerations. This bill has been referred to the Senate Committee on Health, Education, Labor, and Pensions. The House of Representatives passed a companion bill in May.

As the founder and co-chair of the Senate Diabetes Caucus, Senator Collins is also hopeful about the promise that stem cell research holds for a cure for juvenile diabetes.

###